BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 3, 2015
View Archived Issues
Heat Biologics begins trial combining HS-110 and PD-1 checkpoint inhibitor in NSCLC
Read More
Corbus initiates phase II trial of Resunab for systemic sclerosis
Read More
Daktari Diagnostics and Merck & Co. to collaborate on point-of-care HCV test
Read More
Ono Pharmaceuticals presents EP2 receptor agonists
Read More
RXi Pharmaceuticals plans clinical studies of RXI-109 in ophthalmic scarring
Read More
Essex Bio-Technology and Tasly Pharmaceutical collaborate on recombinant protein drugs
Read More
Viking Therapeutics begins trial of VK-5211 for acute hip fracture
Read More
Amgen and Novartis establish neuroscience collaboration in Alzheimer's disease and migraine
Read More
CHDI-003402346, a new clinical candidate for HD
Read More
Dicerna Pharmaceuticals submits IND application to FDA for DCR-PH1
Read More
FDA approves Varubi for nausea and vomiting associated with cancer chemotherapy
Read More
GS-6615 shows short-term efficacy for the treatment of arrhythmia
Read More
FDA grants orphan drug designation to LOXO-101
Read More
Nissan Chemical Industries ends license agreement with Teijin Pharma and BMS for NTC-801
Read More
Novartis receives E.U. approval for Revolade in severe aplastic anemia
Read More
Bristol-Myers Squibb discloses anti-HIV macrocycles
Read More
Janssen introduces anti-HBV agents
Read More
Takeda introduces enteropeptidase inhibitors
Read More
Merck KGaA divulges dual p70S6K/Akt inhibitors
Read More
Incyte patents LSD1 inhibitors
Read More
Suven's 5-HT4 receptor agonist for cognitive dysfunction enters phase I
Read More
Avycaz demonstrates efficacy in phase III trial in cUTI
Read More
Amgen files MAA for etelcalcetide in secondary hyperparathyroidism
Read More
Reduced dose of IL-37 attenuates arterial calcification
Read More
FDA grants fast track designation to intravenous iclaprim
Read More
FDA issues new approval for Emend
Read More